These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 23367699

  • 21. Recombinant proteins and peptides as diagnostic and therapeutic reagents for arthropod allergies.
    Ramos JD, Valmonte GR, de Guia RM.
    Protein Pept Lett; 2007; 14(10):992-1002. PubMed ID: 18220997
    [Abstract] [Full Text] [Related]

  • 22. Anisakis simplex recombinant allergens increase diagnosis specificity preserving high sensitivity.
    Caballero ML, Umpierrez A, Perez-Piñar T, Moneo I, de Burgos C, Asturias JA, Rodríguez-Pérez R.
    Int Arch Allergy Immunol; 2012; 158(3):232-40. PubMed ID: 22398334
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.
    Bolhaar ST, Tiemessen MM, Zuidmeer L, van Leeuwen A, Hoffmann-Sommergruber K, Bruijnzeel-Koomen CA, Taams LS, Knol EF, van Hoffen E, van Ree R, Knulst AC.
    Clin Exp Allergy; 2004 May; 34(5):761-9. PubMed ID: 15144469
    [Abstract] [Full Text] [Related]

  • 24. The current state of recombinant allergens for immunotherapy.
    Pauli G, Malling HJ.
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE, Monasterolo G.
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [Abstract] [Full Text] [Related]

  • 26. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
    Gafvelin G, Thunberg S, Kronqvist M, Grönlund H, Grönneberg R, Troye-Blomberg M, Akdis M, Fiebig H, Purohit A, Horak F, Reisinger J, Niederberger V, Akdis CA, Cromwell O, Pauli G, Valenta R, van Hage M.
    Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
    [Abstract] [Full Text] [Related]

  • 27. A critical assessment of allergen component-based in vitro diagnosis in cherry allergy across Europe.
    Reuter A, Lidholm J, Andersson K, Ostling J, Lundberg M, Scheurer S, Enrique E, Cistero-Bahima A, San Miguel-Moncin M, Ballmer-Weber BK, Vieths S.
    Clin Exp Allergy; 2006 Jun; 36(6):815-23. PubMed ID: 16776683
    [Abstract] [Full Text] [Related]

  • 28. Peptide and recombinant immunotherapy.
    Larché M.
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [Abstract] [Full Text] [Related]

  • 29. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A, Kniest F, Menzel A, Meyer H, Sprung V.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 May; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract] [Full Text] [Related]

  • 30. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
    CMAJ; 1995 May 01; 152(9):1413-9. PubMed ID: 7728690
    [Abstract] [Full Text] [Related]

  • 31. Recombinant allergens and diagnosis of grass pollen allergy.
    Olsen E, Mohapatra SS.
    Ann Allergy; 1994 Jun 01; 72(6):499-506. PubMed ID: 7515604
    [Abstract] [Full Text] [Related]

  • 32. Basophil Activation Test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children.
    Sanz ML, García-Avilés MC, Tabar AI, Anda M, García BE, Barber D, Salcedo G, Rihs HP, Raulf-Heimsoth M.
    Pediatr Allergy Immunol; 2006 Mar 01; 17(2):148-56. PubMed ID: 16618365
    [Abstract] [Full Text] [Related]

  • 33. B-cell epitopes of allergens determined by recombinant techniques; use for diagnosis and therapy of type I allergy.
    Valenta R, Vrtala S, Laffer S, Steinberger P, Ball T, Ferreira F, Scheiner O, Kraft D.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994 Mar 01; (87):235-46. PubMed ID: 7532944
    [Abstract] [Full Text] [Related]

  • 34. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T, Linhart B, Sonneck K, Blatt K, Herrmann H, Valent P, Stoecklinger A, Lupinek C, Thalhamer J, Fedorov AA, Almo SC, Valenta R.
    Allergy; 2009 Apr 01; 64(4):569-80. PubMed ID: 19243361
    [Abstract] [Full Text] [Related]

  • 35. A review of allergy and allergen specific immunotherapy.
    Bidad K, Nicknam MH, Farid R.
    Iran J Allergy Asthma Immunol; 2011 Mar 01; 10(1):1-9. PubMed ID: 21358009
    [Abstract] [Full Text] [Related]

  • 36. Recombinant allergens.
    Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D.
    Allergy; 1998 Jun 01; 53(6):552-61. PubMed ID: 9689336
    [Abstract] [Full Text] [Related]

  • 37. [Practice of hyposensitization in allergic diseases].
    Wüthrich B.
    Schweiz Rundsch Med Prax; 1993 May 04; 82(18):534-9. PubMed ID: 8497763
    [Abstract] [Full Text] [Related]

  • 38. Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children.
    Lasa Luaces EM, Tabar Purroy AI, García Figueroa BE, Anda Apiñaniz M, Sanz Laruga ML, Raulf-Heimsoth M, Barber Hernández D.
    Ann Allergy Asthma Immunol; 2012 May 04; 108(5):367-72. PubMed ID: 22541410
    [Abstract] [Full Text] [Related]

  • 39. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M, Swoboda I, Marth K, Valenta R.
    Clin Exp Allergy; 2010 Mar 04; 40(3):385-97. PubMed ID: 20210812
    [Abstract] [Full Text] [Related]

  • 40. [New concepts in therapy of type I allergic diseases].
    Valenta R, Steinberger P, Vrtala S, Grote M, Laffer S, Sperr WR, Valent P, Kraft D, Scheiner O.
    Wien Klin Wochenschr; 1993 Mar 04; 105(23):682-6. PubMed ID: 7508663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.